Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 3
1956 1
1958 1
1963 3
1964 1
1967 1
1968 3
1969 2
1970 2
1972 1
1973 1
1974 3
1975 2
1976 2
1977 5
1978 4
1979 3
1980 1
1981 1
1982 7
1983 6
1984 13
1985 13
1986 5
1987 7
1988 8
1989 5
1990 8
1991 14
1992 13
1993 12
1994 6
1995 13
1996 8
1997 6
1998 13
1999 5
2000 9
2001 9
2002 12
2003 16
2004 18
2005 13
2006 11
2007 7
2008 7
2009 13
2010 14
2011 4
2012 8
2013 9
2014 10
2015 11
2016 10
2017 12
2018 22
2019 22
2020 23
2021 38
2022 42
2023 34
2024 26
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

581 results

Results by year

Filters applied: . Clear all
Page 1
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.
Tanaka K, Chamoto K, Saeki S, Hatae R, Ikematsu Y, Sakai K, Ando N, Sonomura K, Kojima S, Taketsuna M, Kim YH, Yoshida H, Ozasa H, Sakamori Y, Hirano T, Matsuda F, Hirai T, Nishio K, Sakagami T, Fukushima M, Nakanishi Y, Honjo T, Okamoto I. Tanaka K, et al. Among authors: saeki s. Sci Transl Med. 2022 Dec 14;14(675):eabq0021. doi: 10.1126/scitranslmed.abq0021. Epub 2022 Dec 14. Sci Transl Med. 2022. PMID: 36516270
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, Hamada S, Iyama S, Saruwatari K, Saeki S, Takahashi M, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: saeki s. Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022. Oncoimmunology. 2022. PMID: 35655708 Free PMC article.
Pelvic endometriosis and natural killer cell immunity.
Fukui A, Mai C, Saeki S, Yamamoto M, Takeyama R, Kato T, Ukita Y, Wakimoto Y, Yamaya A, Shibahara H. Fukui A, et al. Among authors: saeki s. Am J Reprod Immunol. 2021 Apr;85(4):e13342. doi: 10.1111/aji.13342. Epub 2020 Sep 21. Am J Reprod Immunol. 2021. PMID: 32896016 Review.
Artificial Intelligence in Academic Writing.
Saeki S. Saeki S. JMA J. 2025 Jan 15;8(1):314-315. doi: 10.31662/jmaj.2024-0224. Epub 2024 Dec 20. JMA J. 2025. PMID: 39926082 Free PMC article. No abstract available.
Social Media for Epidemiological Journals.
Saeki S. Saeki S. J Epidemiol. 2023 May 5;33(5):262-263. doi: 10.2188/jea.JE20230006. Epub 2023 Feb 18. J Epidemiol. 2023. PMID: 36775329 Free PMC article. No abstract available.
581 results